FR2904554B1 - Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples - Google Patents

Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples

Info

Publication number
FR2904554B1
FR2904554B1 FR0705655A FR0705655A FR2904554B1 FR 2904554 B1 FR2904554 B1 FR 2904554B1 FR 0705655 A FR0705655 A FR 0705655A FR 0705655 A FR0705655 A FR 0705655A FR 2904554 B1 FR2904554 B1 FR 2904554B1
Authority
FR
France
Prior art keywords
lmhc
preparation
treatment
methods
carrying multiple
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0705655A
Other languages
English (en)
Other versions
FR2904554A1 (fr
Inventor
Zheng Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIU YING GONG, US
Original Assignee
Zheng Xu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zheng Xu filed Critical Zheng Xu
Publication of FR2904554A1 publication Critical patent/FR2904554A1/fr
Application granted granted Critical
Publication of FR2904554B1 publication Critical patent/FR2904554B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0705655A 2006-08-04 2007-08-02 Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples Active FR2904554B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83544606P 2006-08-04 2006-08-04

Publications (2)

Publication Number Publication Date
FR2904554A1 FR2904554A1 (fr) 2008-02-08
FR2904554B1 true FR2904554B1 (fr) 2010-11-05

Family

ID=38961941

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0705655A Active FR2904554B1 (fr) 2006-08-04 2007-08-02 Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples

Country Status (5)

Country Link
US (1) US7759332B2 (fr)
JP (1) JP5253773B2 (fr)
CN (1) CN101116668B (fr)
CH (1) CH701081B1 (fr)
FR (1) FR2904554B1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2704371A1 (fr) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions et procedes de prevention et de traitement de maladies touchant des mammiferes
US20120115955A1 (en) * 2010-10-04 2012-05-10 Centro De Investigacion Principe Felipe Methods for tumor treatment and adipogenesis differentiation
WO2013039880A1 (fr) * 2011-09-12 2013-03-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Biomarqueurs et cibles thérapeutiques du cancer hépatocellulaire
WO2017214497A1 (fr) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Formulations non comédogènes de soin des cheveux et du cuir chevelu et méthode d'utilisation
CN106176702A (zh) * 2016-07-01 2016-12-07 江南大学 一种辅助维甲酸类药物治疗多种肿瘤的药物组合物
CN118078755A (zh) * 2024-04-19 2024-05-28 赣州市人民医院 一种单链双亲小分子/维生素d3甾醇脂质体及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260067A (en) 1988-11-16 1993-11-09 Xu Zheng Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same
CN1035925C (zh) * 1988-11-16 1997-09-24 许正 亲细胞非均质分子脂质的制备方法
JPH07588B2 (ja) * 1991-11-21 1995-01-11 関本 博 ポリエン酸誘導体
US5874235A (en) * 1997-07-18 1999-02-23 The Johns Hopkins University Screening assays for cancer chemopreventative agents
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
AU2002318427A1 (en) * 2001-06-25 2003-03-03 University Of Massachusetts N-fatty acid-amino acid conjugates and therapeutic uses
US6759416B2 (en) * 2002-08-06 2004-07-06 Panorama Research, Inc. Anticancer conjugates of camptothecin and unsaturated fatty acids

Also Published As

Publication number Publication date
JP2008037868A (ja) 2008-02-21
FR2904554A1 (fr) 2008-02-08
CN101116668B (zh) 2010-09-01
CN101116668A (zh) 2008-02-06
US20080032957A1 (en) 2008-02-07
CH701081B1 (de) 2010-11-30
US7759332B2 (en) 2010-07-20
JP5253773B2 (ja) 2013-07-31

Similar Documents

Publication Publication Date Title
FR2904554B1 (fr) Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples
HK1158754A1 (en) Blood sugar information processor, blood sugar information processing method
Perge et al. Potential relevance of microRNAs in inter-species epigenetic communication, and implications for disease pathogenesis
FR2898603B1 (fr) Nouveaux polyurethanes, compositions les comprenant et procede de traitement cosmetique
PL2142234T3 (pl) Sposób i urządzenie do zalewania pozaustrojowego obiegu krwi
IL196159A0 (en) Mobile apparatus, method and system for processing blood sugar affecting factors
NL2001171A1 (nl) Bewerking van fysiologische signaalgegevens bij patientbewaking.
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
BRPI0716466A2 (pt) Tratamento da calda de açúcar
DK2324871T4 (da) Citratantikoaguleringssystem til ekstrakorporale blodbehandlinger
BRPI0807857A2 (pt) Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
PL2091589T3 (pl) Urządzenie do pozaustrojowej obróbki krwi
EA201290267A1 (ru) Производные диоксабицикло[3.2.1]октан-2,3,4-триола
MA31413B1 (fr) Nouveaux derives de diosmetine, leur procede de preparation pharmaceutiques qui les contiennent.
ZA201301391B (en) Pharmaceutical formulations containing rifaximin,processes for their obtainment and method of treating intestinal disease
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
FR2937972B1 (fr) Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2903404B1 (fr) Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2163896A4 (fr) Procédé de détection ou de traitement de la maladie du greffon contre l'hôte
CY1113040T1 (el) Προφαρμακα δι-εστερα ναλμεφενης
BRPI0908719A2 (pt) Metodos de diagnóstico, prevenção e tratamento de doenças de massa óssea
EP1996732A4 (fr) Détection, traitement de maladies mycobactériennes et découverte de médicaments
FR2911473B1 (fr) Procede, appareil et systeme de preparation de sandwichs.
TWI297075B (en) Detecting system of blood sugar
FR2908965B1 (fr) Ensemble cosmetique et procede de traitement cosmetique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

TP Transmission of property

Owner name: LIU YING GONG, US

Effective date: 20200406

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17